Watchlist Price Alert

Vivos Therapeutics Inc. (VVOS)

NASDAQ: VVOS · Real-Time Price · USD

2.28

0.00 (0.00%)

At close: May 27, 2025, 3:59 PM

2.23

-2.19%

Pre-market: May 28, 2025, 07:00 AM EDT

0.00% (1D)

Bid	1.96
Market Cap	13.43M
Revenue (ttm)	14.63M
Net Income (ttm)	-11.24M
EPS (ttm)	-1.04
PE Ratio (ttm)	-2.19
Forward PE	-2.45
Analyst	Buy

Ask	2.5
Volume	137,795
Avg. Volume (20D)	94,900
Open	2.28
Previous Close	2.28
Day's Range	2.27 - 2.46
52-Week Range	1.91 - 6.28
Beta	7.27

About VVOS

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol VVOS

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for VVOS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 week ago

-16.99%

Vivos Therapeutics shares are trading lower after ... Unlock content with Pro Subscription

3 months ago

+10.9%

Vivos Therapeutics shares are trading higher after the company announced the expansion of its alliance model to two more Colorado locations.

News

1 week ago · seekingalpha.com

Vivos Therapeutics, Inc. (VVOS) Q1 2025 Earnings Call Transcript

Vivos Therapeutics, Inc. (NASDAQ:VVOS ) Q1 2025 Earnings Conference Call May 15, 2025 5:00 PM ET Company Participants Brad Amman - CFO Kirk Huntsman - Chairman and CEO Conference Call Participants Do ...

1 week ago · zacks.com

Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Lags Revenue Estimates

Vivos Therapeutics, Inc. (VVOS) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to loss of $1.63 per share a year ago.

3 weeks ago · zacks.com

Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Vivos Therapeutics (VVOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago · seekingalpha.com

Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call Transcript

Vivos Therapeutics, Inc. (NASDAQ:VVOS ) Q4 2024 Earnings Conference Call March 31, 2025 5:00 PM ET Company Participants Bradford Amman - CFO, Treasurer & Secretary Kirk Huntsman - Co-Founder, Chairman...

1 month ago · zacks.com

Vivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue Estimates

Vivos Therapeutics, Inc. (VVOS) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $3.05 per share a year ago.